工程细菌和细菌衍生物作为炎症性肠病的先进治疗方法
Jingyuan Wu1, Wanlin Ye1, Jie Yu1,2
1School of Medicine, The Chinese University of Hong Kong, Shenzhen, Guangdong, 518172, P. R. China.
Essays in biochemistry
|February 27, 2025
概括
工程化益生菌为炎症性肠病 (IBD) 提供了一个有前途的新疗法. 这些修改后的细菌可以精确地向炎症,改善肠道屏障修复和微生物平衡,以获得更好的患者结果.
科学领域:
- 生物技术和生物医学工程 生物技术和生物医学工程
- 胃肠道学和免疫学
背景情况:
- 炎症性肠病 (IBD) 是一种慢性疾病,常规疗法不足.
- 目前的治疗方法缺乏特异性,引起副作用,无法修复肠道屏障或恢复微生物平衡.
研究的目的:
- 审查工程益生菌的进步,以在IBD中提供向药物.
- 探索增强益生菌局部化到炎症部位的策略,用于治疗分子合成.
主要方法:
- 讨论细菌修饰:表面涂层,基因工程,外膜囊泡,小细胞和细菌幽灵.
- 突出了增强工程细菌治疗局部化的方法.
主要成果:
- 工程细菌和衍生品显示出精确传递和在现场治疗分子合成的潜力.
- 各种修改策略可以增强对炎症部位的局部化.
结论:
- 工程细菌及其衍生物为个性化和持续的IBD治疗提供了一个新的前沿.
- 这些方法有望解决IBD复杂的炎症环境.
相关概念视频
01:29Inflammatory Bowel Disease IV: Pharmacological Management
88
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
88
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
107
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
107
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
92
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
92
01:29Drugs for Treatment of Ulcerative Colitis in IBD
116
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
116
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
130
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
130
01:21Inflammatory Bowel Disease V: Surgical Management
84
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
84